Share on StockTwits

CareDx (NASDAQ:CDNA) posted its quarterly earnings results on Wednesday. The company reported $0.13 earnings per share for the quarter, beating the analysts’ consensus estimate of ($0.13) by $0.26, StockRatingsNetwork reports.

Several analysts have recently commented on the stock. Analysts at Piper Jaffray initiated coverage on shares of CareDx in a research note on Monday, August 11th. They set an “overweight” rating and a $13.00 price target on the stock. On a related note, analysts at Raymond James initiated coverage on shares of CareDx in a research note on Monday, August 11th. They set an “outperform” rating and a $12.50 price target on the stock. Finally, analysts at Leerink Swann initiated coverage on shares of CareDx in a research note on Monday, August 11th. They set an “outperform” rating and a $13.00 price target on the stock.

Shares of CareDx (NASDAQ:CDNA) traded up 1.43% on Wednesday, hitting $9.95. The stock had a trading volume of 13,853 shares. CareDx has a 1-year low of $8.49 and a 1-year high of $10.88. The stock has a 50-day moving average of $9.89 and a 200-day moving average of $9.89. The company’s market cap is $115.1 million.

CareDx, Inc is a commercial stage company that develops markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a patient’s lifetime.

Receive News & Ratings for CareDx Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CareDx Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.